Author

M. List

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 4 Research Focus:cell type annotation· 3 Organism:human· 3 Assay:metagenomics· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

D. Haller· 4 shared S. Reitmeier· 4 shared H. Omer· 2 shared J. Baumbach· 2 shared K. Neuhaus· 2 shared K. Steiger· 2 shared S. Kiessling· 2 shared A. Dietrich· 1 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

D. Haller

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Alternative splicing in mechanically stretched podocytes as a model of glomerular hypertension

F. Mattias, O. Tsoy, E. Hammer, A. Gress, S. Simm, C. T. Lio, S. Ameling, K. Amann, L. Dreher, U. Wenzel, T. Kacprowski, M. List, O. Kalinina, K. Endlich, J. Baumbach, , F. Kliewe

The paper investigates alternative splicing in mechanically stretched podocytes, identifying splicing events in Shroom3 and Myl6 that may contribute to hypertensive nephropathy.

bioRxiv · Jul 17, 2024Cell Biology

Diurnal rhythmicity of fecal microbiota and metabolite profiles in the first year of life: a randomized controlled interventional trial with infant formula

N. Heppner, S. Reitmeier, M. Heddes, M. Vig Merino, L. Schwartz, A. Dietrich, M. List, M. Gigl, C. Meng, H. Omer, K. Kleigrewe, D. R. van der Veen, M. Schirmer, S. Kiessling, D. Haller

This study shows that microbiota and metabolite rhythmicity develops early in life, influenced by diet and breastfeeding, with GOS-supplemented formula promoting bifidobacteria.

bioRxiv · Oct 19, 2023 · PreprintMicrobiology

Mitochondrial perturbation in the intestine causes microbiota-dependent injury and gene signatures discriminative of inflammatory disease

E. Urbauer, D. Aguanno, N. Mindermann, H. Omer, A. Metwaly, T. Krammel, T. Faro, M. Remke, S. Reitmeier, S. Bärthel, J. Kersting, Z. Huang, F. Xian, M. Schmidt, D. Saur, , D. Haller

The paper shows mitochondrial dysfunction in intestinal epithelium leads to microbiota-dependent injury and identifies gene signatures that distinguish active from inactive inflammation in IBD.

bioRxiv · Jul 27, 2023 · PreprintMicrobiology

Gut microbial disruption in critically ill patients with COVID-19 associated pulmonary aspergillosis

D. Schult, C. Maurer, P. Koyumdzhieva, S. Reitmeier, M. Middelhoff, S. Rasch, M. List, K.-P. Janssen, K. Steiger, U. Protzer, R. M. Schmid, K. Neuhaus, D. Haller, M. Quante, T. Lahmer

This study investigates the gut and bronchial microbiota in critically ill COVID-19 patients with and without CAPA, finding reduced gut diversity and increased Staphylococcus epidermidis in CAPA patients.

bioRxiv · Oct 8, 2022Microbiology

Arrhythmic gut microbiome signatures for risk profiling of Type-2 Diabetes

S. Reitmeier, S. Kiessling, T. Clavel, M. List, E. L. Almeida, T. G. Ghosh, K. Neuhaus, M. Troll, H. Grallert, W. Rathmann, B. Linkohr, A. Franke, C. I. Le Roy, J. Bell, T. Spector, , D. Haller

The paper identifies arrhythmic gut microbiome signatures associated with Type-2 Diabetes risk and validates them in a separate cohort.

bioRxiv · Dec 27, 2019Microbiology